THE WOODLANDS, Texas, May 26, 2011 /PRNewswire/ -- McKesson Specialty Care Solutions  | US Oncology , a division of McKesson Corporation , announced today that four physicians affiliated with US Oncology Research  and the United Network of US Oncology  will give oral presentations at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO ) held June 3 - 7 at McCormick Place in Chicago.
ASCO is the world's leading professional organization representing physicians who care for people with cancer. More than 70 McKesson Specialty Care Solutions | US Oncology affiliated oncology experts have contributed to more than 60 studies being featured at this year's major medical meeting.
"US Oncology Research affiliated investigators are consistently on the cutting edge when it comes to the life-changing therapies of the future," said Nicholas Vogelzang , MD, oncologist at Comprehensive Cancer Centers of Nevada , co-chair of the Genitourinary Committee for US Oncology Research, and the communications chair of the 2011 ASCO Annual Meeting. "When it comes to advancing cancer care, these investigators are contributing in a major way. Take the MEK inhibitor study for example. The investigators understand molecular mechanisms, work with companies which have drugs targeting those mechanisms and use them to successfully treat patients in their practices. This is translational research at its best."The four studies being presented orally at ASCO by US Oncology Research affiliated physicians are as